Genetic and environmental influences on malformations of the cardiac outflow tract

Expert Review of Cardiovascular Therapy

Volumn 3, Issue 6, 2005, Pages 1125-1130

  Kuehl, Karen S ^a   Loffredo, Christopher A ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac malformations; Environment; Genetic polymorphisms; Teratogenesis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CHLORINATED HYDROCARBON; FOLIC ACID; NITROFEN; PESTICIDE; RETINOIC ACID; RETINOL;

AIR POLLUTION; CONGENITAL HEART MALFORMATION; ENVIRONMENTAL FACTOR; FALLOT TETRALOGY; FAMILY HISTORY; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GREAT VESSELS TRANSPOSITION; HEART DEVELOPMENT; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEREDITY; HOMOZYGOSITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PREVALENCE; REVIEW; RISK FACTOR; TERATOGENESIS; TERATOGENICITY; XENOBIOTIC METABOLISM;

ANIMALS; ENVIRONMENT; HEART DEFECTS, CONGENITAL; HUMANS;

EID: 28644447880     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.3.6.1125     Document Type: Review

References (44)

1. Hutson MR, Kirby ML. Neural crest and cardiovascular development: a 20 year perspective. Birth Defects Res. Part C. Embryo Today 69, 2-13 (2003).
2. Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD. Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore Washington Infant Study: 1981-1989. Futura Armonk (1997).
3. Ferencz C, Rubin JD, McCarter RJ et al. Hematologic disorders and congenital cardiovascular malformations: converging lines of research. J. Med. 15(5-6), 337-354 (1984).
4. Digilio MC, Casey B, Toscano A et al. Complete transposition of the great arteries: patterns of congenital heart disease in familial precurrence. Circulation 104(23), 2809-2814 (2001).
5. Franco D, Campione M. The role of Pitx2 during cardiac development. Trends Cardiovasc. Med. 13, 157-163 (2003).
6. Conway SJ, Henderson DJ, Kirby ML, Anderson RH, Copp AJ. Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse. Cardiovasc. Res. 36, 163-173 (1997).
7. Bruneau BG, Nemer G, Schmitt JP et al. Murine model of Holt Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106, 709-721 (2001).
8. Krantz ID, Smith R, Colliton RP et al. Jagged1 mutations in patients ascertained with isolated congenital heart defects. Cell Am. J. Med. Genetics 84, 56-60 (1999).
9. Benson DW, Silberbach GM, Kavanaugh-McHugh A et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J. Clin. Invest. 104, 1567-1573 (1999).
10. McElhinney DB, Geiger E, Blinder J et al. NKX 2.5 mutations in patients with congenital heart disease. J. Am. Coll. Cardiol. 42(9), 1650-1655 (2003).
11. Basson CT, Huant T, Lin RC et al. Different TBX5 interactions in heart and limb defined by Holt Oram syndrome mutations. Proc. Natl Acad. Sci. USA 96, 2919-2924 (1999).
12. Rothman KJ, Moore LL, Singer MR et al. Teratogenicity of high vitamin A intake. N. Engl. J. Med. 333, 1369-1373 (1995).
13. Botto LD, Loffredo C, Scanlon KS et al. Vitamin A and cardiac outflow tract defects. Epidemiology 12, 491-496 (2001).
14. Mulder GB, Manley N, Grant J et al. Effects of excess vitamin A on development of cranial neural crest derived structures: a neonatal and embryologic study. Teratology 62, 214-226 (2000).
15. Wilson JG, Warkany J. Cardiac and aortic arch anomalies in the offspring of vitamin A deficient rats correlated with similar human anomalies. Peds. Apr. 5(4), 708-725 (1950).
16. Gruber PJ, Kubalak SW, Pexieder T, Sucov HM, Evans RM, Chien KR. RXR α deficiency confers genetic susceptibility for aortic sac, conotruncal, atrioventricular cushion, and ventricular muscle defects in mice. J. Clin. Invest. 98(6), 1332-1343 (1996).
17. Zile MH, Kostetskii I, Yuan S et al. Retinoid signaling is required to complete the vertebrate cardiac left/right asymmetry pathway. Dev. Biol. 223(2), 323-338 (2000).
18. Botto LD, Mulinare J, Erickson JD. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Am. J. Med. Genet. 121A, 95-101 (2003).
19. Czeizel AE. Periconceptional folic acid containing multivitamin supplement. Eur. J. Obstet. Reprod. Biol. 78, 151-161 (1998).
20. Junker R, Kotthoff S, Vielhaber H et al. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiov. Res. 51, 251-254 (2001).
21. Wenstrom KD, Johanning GL, Johnston KE, DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am. J. Obstet. Gynecol. 184, 806-812 (2001).
22. Shaw GM, Zhu H, Lammer EJ et al. Genetic variation of infant reduced folate carrier [A80G] and risk of orofacial and conotruncal heart defects. Am. J. Epidemiol. 158, 747-752 (2003).
23. Gelineau van Waes J, Tang L, Aleman F et al. Maternal folate reduces neural crest cell derived conotruncal heart defects in Folbp1 knock out mice. Teratology 65(6), 302 (2002).
24. Goldberg SJ, Lebowitz MD, Graver EJ, Hicks S. An association of human congenital cardiac malformations and drinking water contaminants. J. Am. Coll. Cardiol. 16, 155-164 (1990).
25. Swan SH, Shaw G, Harris JA, Neutra RR. Congenital cardiac anomalies in relation to water contamination in Santa Clara County California 1981-1983. Am. J. Epidemiol. 129, 885-893 (1989).
26. Johnson PD, Dawson BV, Goldberg SJ. Cardiac teratogenicity of trichloroethylene metabolites. JACC 32, 540-545 (1998).
27. Han HS, Ishikawa S, Nazaki Y et al. Morphology and pathogenesis of cardiovascular malformations induced by dichloroethylene [DCE] in chick embryos Showa. Univ. J. Med. Sci. 6, 49-59 (1994).
28. Yu J, Gonzalez S, Rodriguez JI et al. Neural crest-derived defects in experimental congenital diaphragmatic hernia. Pediatr. Surg. Int. 17, 294-298 (2001).
29. Kuribayashi T, Roberts WC. Tetralogy of fallot, truncus arteriosus abnormal myocardial architecture and anomalies of the aortic arch system induced by bis-diamine in rat fetuses. J. Am. Coll. Cardiol. 21, 768-776 (1993).
30. Ritz B, Yu F, Fruin S et al. Ambient air pollution and the risk of birth defects in Southern California. Am. J. Epidemiol. 155, 17-25 (2002).
31. Abushaban L, AL-Hay A, Uthaman B et al. Impact of the Gulf War on congenital heart diseases in Kuwait. Int. J. Cardiol. 93, 157-162 (2004).
32. Bianca S, Dipasquale R, DeLuca G et al. Sex ratio imbalance in transposition of the great arteries and parental agricultural occupation. Reprod. Toxicol. 16, 436 (2002).
33. Loffredo CA, Silbergeld EK, Ferencz C, Zhang J. Association of transposition of the great arteries in infants with maternal exposures to herbicides and rodenticides. Am. J. Epidemiol. 153(6), 529-536 (2001).
34. Loffredo CA and Silbergeld EK. Sex differences in human glutathione-S-transferase genes. Fundame. Appl. Toxicol. 36, 101-102 (1997).
35. Kuehl KS and Loffredo CA. Population-based study of L-transposition of the great arteries: possible associations with environmental factors. Birth Defects Res. Part A: Clin. Mol. Teratol. 67(3), 162-167 (2003).
36. Shaw GM, Nelson V, Iovannisci DM et al. Maternal occupational chemical exposures and biotransformation genotypes as risk factors for selected Congenital Anomalies. Am. J. Epidemiol. 157, 475-482 (2003).
37. Ewing CK, Loffredo CA, Beatty TH. Paternal risk factors for isolated membranous ventricular septal defects. Am. J. Med. Genet. 71(1), 42-46 (1997).
38. Engel RR, Smith AH. Arsenic in drinking water and mortality from vascular disease. Arch. Environ. Health 49, 418-427 (1994).
39. Zierler S, Theodore M, Cohen A, Rothman KJ. Chemical quality of maternal drinking water and congenital heart disease. Int. J. Epidemiol. 17(3), 589-594 (1998).
40. Smoak IW. Brief hypoglycemia alters morphology, function, and metabolism of the embryonic mouse heart. Reprod. Toxicol. 11, 495-502 (1997).
41. Loffredo CA. Epidemiology of cardiovascular malformations: prevalence and risk factors. Am. J. Med. Genet. 97(4), 319-325 (2000).
42. Delise BL, Chalier C, Hodge T. Teratogenicity of an endothelin receptor-A antagonist in rats and rabbits. Teratology 63, 283 (2001).
43. Okuda H, Ohta R, Wada A et al. Persistence of phenobarbital induced cardiovascular abnormalities in the rat to the postnatal stage. Teratology 50, 20B (1994).
44. Sonoda T, Fukunga K, Tashiro S, Obha K, Fujimoto T. Carbamazepine-induced cardiovascular abnormalities in chick embryos. Congen. Anom. 3, 115-120 (1996).